Knoepfler is STAT’s Lab Dish columnist and a professor of cell biology and human anatomy at UC Davis School of Medicine. De-extinction firm Colossal Biosciences announced Tuesday that it was acquiring ...

Colossal Biosciences has announced its first acquisition, bringing Viagen Pets and Equine, the world leader in animal cloning, into its growing biotechnology family. Viagen made headlines a few years ...

A year ago, Colossal Biosciences introduced to the world their version of the dire wolf, an animal extinct for over 12,500 years. The company’s scientists are hoping to bring back the woolly mammoth ...

Colossal Biosciences announced on March 4, 2025, that it had created what it calls the “Colossal Woolly Mouse,” a living mouse engineered with multiple mammoth-like hair traits through simultaneous ...

Add Yahoo as a preferred source to see more of our stories on Google. Colossal Biosciences, the company that produced a trio of modern-day dire wolves, now has its own answer to the question: What ...

In an early step towards artificial wombs, a biotech company claims it’s developed a “fully artificial” chicken egg. The baby chicks were shifting and starting to pip—or trying to hatch. But not from ...

In a scientific breakthrough that could forever change how humans interact with our planet, Colossal Biosciences said it has brought back an extinct animal that last walked the Earth roughly 10,000 ...

Add Yahoo as a preferred source to see more of our stories on Google. Colossal Biosciences, best known for its headline-grabbing mission to resurrect the woolly mammoth, is now pointing its ...

In a landmark move that underscores the shifting paradigm of global venture capital, the United Arab Emirates has finalized a nine-figure partnership with Colossal Biosciences, the Texas-based leader ...

When the elevator doors part on the second floor of a two-story brick and glass building in an office park on the outskirts of downtown Dallas, it feels like a portal opening to a different world. The ...